Skip to main content
. 2021 Jan 29;112(3):1275–1288. doi: 10.1111/cas.14807

TABLE 2.

Univariate and multivariate analysis of DFS

Univariate Multivariate
HR 95% CI P value HR 95% CI P value
Age (≥70/<70) 2.5059 0.9972‐6.2974 .0507
Sex (male/female) 3.0757 1.1404‐8.2949 .0264 4.0486 1.3768‐11.9048 .0110
Hepatitis B virus surface antigen (±) 0.9516 0.3264‐2.7742 .9277
Anti‐hepatitis C virus antibody (±) 1.3645 0.6194‐3.0058 .4405
Child‐Pugh classification (A/B) 1.0035 0.2347‐4.2899 .9962
Alpha‐fetoprotein (≥20/<20 ng/mL) 0.9471 0.4290‐2.0908 .8931
Des‐γ‐carboxy prothrombin (≥100/<100 mAU/mL) 3.7439 1.2798‐10.9525 .0159 3.6223 1.1524‐11.3859 .0276
Tumor size (≥5/<5 cm) 2.3437 1.0475‐5.2438 .0382 1.2664 0.4991‐3.2135 .6190
Number of tumors (multiple/single) 3.1849 1.1738‐8.6416 .0229 3.6273 1.0927‐12.0402 .0353
Histological differentiation (poorly/well, moderately) 2.3048 1.0441‐5.0876 .0387 1.7253 0.7344‐4.0532 .2107
Microscopic portal vein invasion (±) 1.3128 0.5650‐3.0502 .5269
Liver cirrhosis (±) 1.2455 0.5650‐2.7457 .5861
miR‐638 expression (high/low) 2.6354 1.1293‐6.1503 00250 3.2128 1.2972‐7.9567 .0117

CI, confidence interval, DFS, disease‐free survival, HR, hazard ratio, miR, microRNA.